Studies using filaggrin-mutant mice demonstrate that IL-1β production is significantly elevated in inflamed skin and that blocking IL-1β signaling reduces inflammation, suggesting its critical importance in the pathogenesis of atopic dermatitis [88]. Here, IL1B is linked to atopic eczema.